Dr Yoo Young (Dominique) Lee

MBChB, FRANZCR
肿瘤放疗科医生
Become a Patient

Dr Yoo Young (Dominique) Lee is dedicated to providing her patients with the highest level of care to achieve the best possible outcome.

Biography

Dr Yoo Young (Dominique) Lee is a consultant radiation oncologist at Icon Cancer Centre Greenslopes. She completed her Bachelor of Medicine, Bachelor of Surgery (MBChB) at the University of Otago before commencing specialist radiation oncology training at Auckland City Hospital and Sydney’s Liverpool Hospital. In 2014, Dr Lee became a fellow of the Royal Australian and New Zealand College of Radiologists (FRANZCR) and subsequently completed a clinical research fellowship at Westmead Hospital, investigating stereotactic ablative radiation therapy (SABR) treatment for liver, spine and bone metastases.

Dr Lee maintains a strong interest in clinical research with a particular focus on stereotactic ablative radiation therapy (SABR). She is an active member of several leading cancer trial groups including Australasian Gastro-Intestinal Cancer Trials Group (AGITG) and Trans Tasman Radiation Oncology Group (TROG). In collaboration with TROG, Dr Lee is the trial chair of an international clinical study TROG 17.03 (LARK). Recently she has joined Cancer Australia’s National Pancreatic Cancer Roadmap Steering Group as the Royal Australian and New Zealand College of Radiologists (RANZCR) representative.

Her clinical experience covers a broad range of solid tumour malignancies with special clinical interest in lymphoma, gastrointestinal, hepatobiliary, skin cancers and palliative care. Dr Lee can converse in Korean and looks forward to working with patients in their language.

Affiliations & Memberships

  • Australasian Gastro-Intestinal Cancer Trials Group (AGITG)
  • Royal Australian and New Zealand College of Radiologists (RANZCR)
  • Trans Tasman Radiation Oncology Group (TROG)

Special Interests

Dr Yoo Young (Dominique) Lee accepts referrals for all cancer types, with a special clinical interest in:
  • Gastrointestinal cancer
  • Lymphoma
  • Palliative care
  • Skin cancer
  • Stereotactic radiation therapy

Visiting Locations

  • Princess Alexandra Hospital

Publications

  • Stereotactic radiotherapy for hepatocellular carcinoma: Expanding the multidisciplinary armamentarium. M. Shanker, H. Liu, Lee, K Stuart, E Powell, A Wigg & D Pryor. Journal of Gastroenterology and Hepatology, 2020.

  • Intrafraction cone beam computed tomography verification of breath hold during liver stereotactic radiation therapy. E. Brown, E. Muscat, P. O’Conor, H. Hiu, Y.Lee & D. Pryor. Journal of Medical Radiation Sciences, 2020.

  • Efficacy and Toxicity of Stereotactic Body Radiotherapy for Early to Advanced Stage Hepatocellular Carcinoma – Initial Experience From an Australian Liver Cancer Service. Y. Liu, Y. Lee, K. McLean, D. Leggett, P. Hodgkinson, J. Fawcett & R. Mott. Clinical Oncology, 2020; 32(10).

  • Australasian Gastrointestinal Trials Group (AGITG) and Trans-Tasman Radiation Oncology Group (TROG) Guidelines for Pancreatic Stereotactic Body Radiation Therapy (SBRT). A. Oar, M. Lee, H. Le, G. Hruby, D. Pryor, Lee & J. Chu. Practical Radiation Oncology, 2020; 10(3): 136-146.

  • Breast irradiation causes pallor in the nipple‐areolar complex in women with Celtic skin type (result from the St. George and Wollongong randomised breast boost trial). Y. Lee, E. Hau, L.H. Browne, Y. Chin, J. Lee, A. Szwajcer, S. Cail, D.N. Nolan & P.H. Graham. Journal of Medical Imaging and Radiation Oncology, 2014.